Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Liver Transplantation
2015年8月27日 更新者:WonHo Kim、Samsung Medical Center
The incidence of acute kidney injury after liver transplantation has been reported to be 17 to 95 percent, but no definite treatment has been reported yet.
Therefore, it is important to identify and prevent reversible risk factors for acute kidney injury after liver transplantation.
Previous studies have reported several preoperative clinical risk factors, but preoperative medication and intraoperative colloid administration and hemodynamic parameters have not been evaluated.
Therefore, we attempt to evaluate perioperative risk factors and develop simplified clinical risk scoring model.
研究概览
详细说明
Ischemia/reperfusion injury occurs during graft harvesting, cold storage, and surgical procedures in liver transplantation.
Ischemia/reperfusion injury in liver graft results in major organ damage including kidney, lung and heart as well as graft dysfunction.
Graft dysfunction and renal injury after liver transplantation are major clinical issues and are associated with prognosis and low survival rate.
The incidence of acute kidney injury after liver transplantation has been reported to be 17 to 95 percent, but no definite treatment has been reported yet.
Therefore, it is important to identify and prevent reversible risk factors for acute kidney injury after liver transplantation.
Previous studies have reported several preoperative clinical risk factors, but perioperative medication, metabolic variables (albumin, glucose, uric acid), intraoperative colloid administration and hemodynamic parameters have not been evaluated.
In addition, a neutrophil-lymphocyte ratio (NLR), which has been reported to be related to systemic inflammation and associated with prognosis of cardiac and cancer patients, might be related to the development of AKI after LDLT.
Therefore, we attempt to evaluate these perioperative risk factors and develop simplified clinical risk scoring model.
研究类型
观察性的
注册 (实际的)
573
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Seoul、大韩民国、135-710
- Samsung Medical Center
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
20年 至 70年 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
取样方法
非概率样本
研究人群
patients who underwent living donor liver transplantation between 2010 and 2013
描述
Inclusion Criteria:
- Patients who underwent living donor liver transplantation between 2010 and 2013 in Samsung Medical Center
Exclusion Criteria:
- Incomplete data regarding pre- and postoperative creatinine and estimated Glomerular Filtration Rate
- patient who underwent retransplantation
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
liver transplantation
patients who underwent living donor liver transplantation during between 2007 and 2013
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
acute kidney injury as defined by RIFLE criteria
大体时间:during 7 days after transplantation
|
acute kidney injury as defined by RIFLE criteria
|
during 7 days after transplantation
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
incidence of renal replacement therapy
大体时间:during one month after transplantation
|
renal replacement therapy
|
during one month after transplantation
|
|
incidence of acute rejection of graft
大体时间:during one month after transplantation
|
incidence of acute rejection of graft
|
during one month after transplantation
|
|
incidence of initial poor graft function
大体时间:during one month after transplantation
|
incidence of initial poor graft function
|
during one month after transplantation
|
|
incidence of retransplantation
大体时间:during one month after transplantation
|
incidence of retransplantation
|
during one month after transplantation
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Mortality
大体时间:during one month, six month, one year
|
Mortality during one month, six month, one year
|
during one month, six month, one year
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2014年1月1日
初级完成 (实际的)
2015年6月1日
研究完成 (实际的)
2015年6月1日
研究注册日期
首次提交
2014年3月4日
首先提交符合 QC 标准的
2014年3月5日
首次发布 (估计)
2014年3月6日
研究记录更新
最后更新发布 (估计)
2015年8月28日
上次提交的符合 QC 标准的更新
2015年8月27日
最后验证
2015年8月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.